Skip to content

Spouses/Partners Expressing Their Thoughts After Transplant

Emotional Expression and Cancer Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01061801
Enrollment
122
Registered
2010-02-03
Start date
2006-08-31
Completion date
2009-07-31
Last updated
2010-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Hematopoietic Stem Cell Transplantation

Keywords

caregivers, cancer, emotion, protective buffering

Brief summary

This study seeks to test a brief psychological intervention for spousal caregivers of cancer patients (specifically, hematopoietic stem cell transplant patients), persons known to experience emotional distress.

Detailed description

This project focuses on spousal caregivers (CGs) of hematopoietic stem cell transplant survivors - persons known to report elevated levels of distress as compared to both norms and their patient counterparts. Specific Aims are to: (1) Determine, via experimental manipulation, whether or not CGs of hematopoietic stem cell transplant patients engage in protective buffering, a coping mechanism whereby partners shield patients from illness-related concerns or worries, (2) Examine synchrony or lack thereof, desynchrony, among subjective, expressive and biologic indicators of emotion among spousal CGs, and (3) Test the feasibility and implementation of an emotional expression (EE) exercise designed to enhance psychological and immune functioning among spousal CGs.

Interventions

BEHAVIORALEmotional expression

Caregivers are given the opportunity to express their thoughts and feelings regarding the patient's transplant and their role as caregiver

Sponsors

University of Washington
CollaboratorOTHER
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients and partners at least 21 years of age * patients and partners English speaking * patients about to receive a hematopoietic stem cell transplant * patients married or in a committed, cohabiting, heterosexual or homosexual relationship * caregivers in a married or committed, cohabiting, heterosexual or homosexual relationship with the patient * caregivers present at the transplant site and planning to remain so for at least one month

Exclusion criteria

* patient major psychiatric disorder * caregiver presence or history of a neurologic disorder

Design outcomes

Primary

MeasureTime frame
Self-reported mental and physical health as measured by the Short Form-36 Health Surveybaseline, 1-month follow-up, and 4-month follow-up
Marital satisfaction as measured by the Dyadic Adjustment Scalepre-transplant, baseline, 1-month follow-up, and 4-month follow-up
Self- and partner-reported protective buffering as measured by the Protective Buffering Scalepre-transplant, baseline, 1-month follow-up, and 4-month follow-up

Secondary

MeasureTime frame
Emotional experience as assessed by the Positive and Negative Affect ScheduleDuring intervention/ disclosure sessions
Galvanic skin response (physiological indicator of emotion)During intervention/ disclosure sessions
Emotional expression (facial expression and words uttered)During intervention/ disclosure sessions

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026